Unlock instant, AI-driven research and patent intelligence for your innovation.

High-efficiency expression method of recombinant human endomucin in Escherichia coli

A technology of Escherichia coli and an expression method, applied in the field of biopharmaceuticals, can solve problems such as the high-efficiency expression of recombinant human Endomucin that has not yet been reported, and achieve the effect of high-efficiency expression

Active Publication Date: 2015-09-30
ZHONGYI ANKE BIOTECH CO LTD +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the high expression of recombinant human Endomucin in Escherichia coli has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High-efficiency expression method of recombinant human endomucin in Escherichia coli
  • High-efficiency expression method of recombinant human endomucin in Escherichia coli
  • High-efficiency expression method of recombinant human endomucin in Escherichia coli

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] 1) Clone the full-length human Endomucin gene into pGEX-2T expression plasmid. The restriction enzymes used are BamH I at the N-terminus and RcoRI at the C-terminus to connect the target gene to glutathione sulfhydryl transferase. After the (GST) gene, insert a thrombin cut site between the GST and Endomucin genes to construct a new cloning plasmid pGEX-Endomucin to express the GST-Endomucin fusion protein.

[0026] 2) Using Escherichia coli BL21(DE3)(plySs) strain as the host strain for expressing Endomucin protein, transforming the pGEX-Endomucin plasmid into E. coli BL21(DE3)(plySs) to construct an engineered E. coli strain capable of expressing GST-Endomucin fusion protein BL21-GEn.

[0027] 3) On the expression process of GST-Endomucin fusion protein, the specific process steps are:

[0028] ① Streak the E. coli engineering strain BL21-GEn to inoculate the LB semi-solid medium (containing 100ug / mL Amp), invert the culture overnight at 37°C, until a single colony of the e...

Embodiment 2

[0035] 1) Clone the full-length human Endomucin gene into the pGEX-2T expression plasmid. The restriction enzymes used are BamH I at the N-terminus and RcoRI at the C-terminus to connect the target gene to glutathione sulfhydryl transferase. After the (GST) gene, insert a thrombin cleavage site between the GST and Endomucin genes to construct a new cloning plasmid pGEX-Endomucin to express the GST-Endomucin fusion protein.

[0036] 2) Using Escherichia coli BL21(DE3)(plySs) strain as the host strain for expressing Endomucin protein, transforming the pGEX-Endomucin plasmid into E. coli BL21(DE3)(plySs) to construct an engineered E. coli strain capable of expressing GST-Endomucin BL21-GEn.

[0037] 3) In the expression process of GST-Endomucin fusion protein, the specific process steps are:

[0038] ① Streak the E. coli engineering strain BL21-GEn to inoculate the LB semi-solid medium (containing 100ug / mL Amp), invert the culture overnight at 37°C, until a single colony of the enginee...

Embodiment 3

[0045] 1) Clone the full-length human Endomucin gene into the pGEX-2T expression plasmid. The restriction enzymes used are BamH I at the N-terminus and RcoRI at the C-terminus to connect the target gene to glutathione sulfhydryl transferase. After the (GST) gene, insert a thrombin cleavage site between the GST and Endomucin genes to construct a new cloning plasmid pGEX-Endomucin to express the GST-Endomucin fusion protein.

[0046] 2) Using Escherichia coli BL21(DE3)(plySs) strain as the host strain for expressing Endomucin protein, transforming the pGEX-Endomucin plasmid into E. coli BL21(DE3)(plySs) to construct an engineered E. coli strain capable of expressing GST-Endomucin BL21-GEn.

[0047] 3) In the expression process of GST-Endomucin fusion protein, the specific process steps are:

[0048] ① Streak the E. coli engineering strain BL21-GEn to inoculate the LB semi-solid medium (containing 100ug / mL Amp), invert the culture overnight at 37°C, until a single colony of the enginee...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a high-efficiency expression method of recombinant human Endomucin in Escherichia coli, through the development of GST-Endomucin fusion protein strategy, the transformation of the expression plasmid and the expression host of the recombinant human Endomucin membrane protein that is difficult to express in Escherichia coli The optimization of bacterial strains and the development of expression technology have achieved the purpose of preparing a large amount of recombinant human Endomucin.

Description

technical field [0001] The invention provides a high-efficiency expression method of recombinant human Endomucin in Escherichia coli, belonging to the technical field of biopharmaceuticals. Background technique [0002] The "recombinant human Endomucin" involved in the present invention is a transmembrane protein expressed on the membrane surface of hematopoietic stem cells. Endoumcin was discovered by Morgan in the mouse endothelial cell line in 1999. Its expression is specific to the membrane surface of hematopoietic progenitor cells, adult hematopoietic stem cells and multipotent progenitor cells in development, and has a similar structure to mucin-like glycoproteins. The expression of Endomucin is closely related to the expression of two important marker molecules on the membrane surface of hematopoietic stem cells: c-Kit and Sca-1. Moreover, Endomucin can replace c-Kit and Sca-1 to identify hematopoietic stem cells alone. Endomucin, as the newly discovered most import...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/70C12P21/02C07K14/47C07K1/36C07K1/22C07K1/16
Inventor 王群鞠长军高俊芳
Owner ZHONGYI ANKE BIOTECH CO LTD